Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Fosamprenavir> ?p ?o. }
Showing items 1 to 83 of
83
with 100 items per page.
- Fosamprenavir abstract "Fosamprenavir (marketed by ViiV Healthcare as fosamprenavir calcium), under the trade names Lexiva (U.S.) and Telzir (Europe) is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. The FDA approved it October 20, 2003, while the EMEA approved it on July 12, 2004. The human body metabolizes fosamprenavir in order to form amprenavir, which is the active ingredient. That metabolization increases the duration that amprenavir is available, making fosamprenavir a slow-release version of amprenavir and thus reducing the number of pills required versus standard amprenavir.A head-to-head study with lopinavir showed the two drugs to have comparable potency, but patients on fosamprenavir tended to have a higher serum cholesterol. Fosamprenavir's main advantage over lopinavir is that it is cheaper.".
- Fosamprenavir atcPrefix "J05".
- Fosamprenavir atcSuffix "AE07".
- Fosamprenavir casNumber "226700-81-8".
- Fosamprenavir drugbank "DB01319".
- Fosamprenavir fdaUniiCode "WOU1621EEG".
- Fosamprenavir iupacName "{[(2R,3S)-1-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-3-({[(3S)-oxolan-3-yloxy]carbonyl}amino)-4-phenylbutan-2-yl]oxy}phosphonic acid".
- Fosamprenavir pubchem "131536".
- Fosamprenavir thumbnail Fosamprenavir.svg?width=300.
- Fosamprenavir wikiPageID "4935908".
- Fosamprenavir wikiPageRevisionID "566112026".
- Fosamprenavir atcPrefix "J05".
- Fosamprenavir atcSuffix "AE07".
- Fosamprenavir bioavailability "Unknown".
- Fosamprenavir c "25".
- Fosamprenavir casNumber "226700".
- Fosamprenavir chembl "1664".
- Fosamprenavir chemspiderid "116245".
- Fosamprenavir drugbank "DB01319".
- Fosamprenavir eliminationHalfLife "27720.0".
- Fosamprenavir excretion "Fecal".
- Fosamprenavir h "36".
- Fosamprenavir hasPhotoCollection Fosamprenavir.
- Fosamprenavir image "Fosamprenavir ball-and-stick.png".
- Fosamprenavir inchi "1".
- Fosamprenavir inchikey "MLBVMOWEQCZNCC-OEMFJLHTBM".
- Fosamprenavir iupacName "{[-1-[N-sulfonamido]-3--4-phenylbutan-2-yl]oxy}phosphonic acid".
- Fosamprenavir legalStatus "℞-only , POM".
- Fosamprenavir medlineplus "a604012".
- Fosamprenavir metabolism "Hydrolysed to amprenavir and phosphate in GI tract epithelium".
- Fosamprenavir molecularWeight "585.608".
- Fosamprenavir molecularWeight "623.7".
- Fosamprenavir n "3".
- Fosamprenavir niaidChemdb "82186".
- Fosamprenavir o "9".
- Fosamprenavir p "1".
- Fosamprenavir pregnancyCategory "C".
- Fosamprenavir proteinBound "90.0".
- Fosamprenavir pubchem "131536".
- Fosamprenavir routesOfAdministration "Oral".
- Fosamprenavir s "1".
- Fosamprenavir smiles "O=CN[C@@H][C@H]CNSc3ccccc3".
- Fosamprenavir stdinchi "1".
- Fosamprenavir stdinchikey "MLBVMOWEQCZNCC-OEMFJLHTSA-N".
- Fosamprenavir tradename "Lexiva".
- Fosamprenavir unii "WOU1621EEG".
- Fosamprenavir verifiedfields "changed".
- Fosamprenavir verifiedrevid "461113196".
- Fosamprenavir subject Category:Carbamates.
- Fosamprenavir subject Category:Prodrugs.
- Fosamprenavir subject Category:Protease_inhibitors.
- Fosamprenavir subject Category:Sulfonamides.
- Fosamprenavir subject Category:Tetrahydrofurans.
- Fosamprenavir type Agent114778436.
- Fosamprenavir type Antibacterial102716205.
- Fosamprenavir type Antiviral102725367.
- Fosamprenavir type CausalAgent100007347.
- Fosamprenavir type Drug103247620.
- Fosamprenavir type Matter100020827.
- Fosamprenavir type Medicine103740161.
- Fosamprenavir type PhysicalEntity100001930.
- Fosamprenavir type ProteaseInhibitor104013993.
- Fosamprenavir type ProteaseInhibitors.
- Fosamprenavir type Substance100020090.
- Fosamprenavir type SulfaDrug104352070.
- Fosamprenavir type Sulfonamides.
- Fosamprenavir type Drug.
- Fosamprenavir type DrugProduct.
- Fosamprenavir type FunctionalSubstance.
- Fosamprenavir comment "Fosamprenavir (marketed by ViiV Healthcare as fosamprenavir calcium), under the trade names Lexiva (U.S.) and Telzir (Europe) is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. The FDA approved it October 20, 2003, while the EMEA approved it on July 12, 2004. The human body metabolizes fosamprenavir in order to form amprenavir, which is the active ingredient.".
- Fosamprenavir label "Fosamprenavir".
- Fosamprenavir label "Fosamprenavir".
- Fosamprenavir label "Fosamprenavir".
- Fosamprenavir sameAs Fosamprenavir.
- Fosamprenavir sameAs Fosamprenavir.
- Fosamprenavir sameAs m.0cv_64.
- Fosamprenavir sameAs Q1385311.
- Fosamprenavir sameAs Q1385311.
- Fosamprenavir sameAs DB01319.
- Fosamprenavir sameAs Fosamprenavir.
- Fosamprenavir wasDerivedFrom Fosamprenavir?oldid=566112026.
- Fosamprenavir depiction Fosamprenavir.svg.
- Fosamprenavir isPrimaryTopicOf Fosamprenavir.